Synthetic, biocatalytic acetylation and anti-tuberculosis activity evaluation studies on (±)-4-alkyl-3,4-dihydro-3-ω -hydroxyalkyl-2H-1,3-benzoxazines

Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry

Volumn 42, Issue 8, 2003, Pages 1958-1969

  Shakil, Najam A ^a,d   Dhawan, Ashish ^a,d   Sharma, Nawal K ^a   Kumar, Vijayendra ^a,d   Kumar, Sujeet ^b   Bose, Mridula ^b   Raj, Hanumantharao G ^b   Olsen, Carl E ^c   Cholli, Ashok L ^d   Samuelson, Lynne A ^d   Kumar, Jayant ^d   Watterson, Arthur C ^d   Parmar, Virinder S ^a,d   Prasad, Ashok K ^a  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF DELHI   (India)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d University of Massachusetts Lowell   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2H 1,3 BENZOXAZINE; ALCOHOL; AMINE; ANTIMYCOBACTERIAL AGENT; BENZOXAZINE DERIVATIVE; FORMALDEHYDE; SCHIFF BASE; TETRAHYDROFURAN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOCATALYST; CATALYSIS; CHIRALITY; DRUG ACETYLATION; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; MANNICH REACTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REACTION ANALYSIS; STRUCTURE ANALYSIS;

EID: 0141481257     PISSN: 03764699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rigterink R H, USP 2,806,031/1957; Chem Abstr, 52, 1958, 8210.
2. Chylinska J B, Janowiec T, Urbanski T & Venolet J, Pol P 48, 464/1965; Chem Abstr, 64, 1966, 15895.
3. Gomezgomez P, Perez M, Carvajal A & Rincon J M, Rev Colomb Cienc Quim Farm 4, 1985, 15; Chem Abstr, 104, 1986, 165195.
4. Gomezgomez P, Perez M, Carvajal A & Rincon J M, Rev Colomb Cienc Quim Farm 4, 1985, 15; Chem Abstr, 104, 1986, 165195.
5. Chylinska J B, Urbanski T & Mordarski M, J Med Chem, 6, 1963, 484.
6. Chylinska J B, Janowiec M & Urbanski T, Br J Pharmacol, 43, 1971, 649.
7. Kovalensko F P, Chem Abstr, 92, 1980, 141168.
8. Kuehne M E, USP 3,133,919/1964; Chem Abstr, 61, 1964, 5662.
9. Burke W J, J Am Chem Soc, 71, 1949, 609.
10. Asymmetric Synthesis. Aitken R A & Kilenyi S N, Blackie Academic & Professional: London 1992.
11. Zaks A & Dodds, D R, Drug Discovery Today, 2, 1997, 513.
12. Parmar V S, Pati H N, Yadav R P, Kumar A, Bisht K S, Gupta R, Davidson S W, Poonam & Saxena R K, Biocat Biotrans, 16, 1998, 17.
13. Parmar V S, Prasad A K, Sharma N K, Singh S K, Pati H N & Gupta S, Tetrahedron, 48, 1992, 6495.
14. Bisht K S, Tyagi OD, Prasad A K, Sharma N K. Gupta S & Parmar V S, Bioorg Med Chem, 2, 1994, 1015.
15. Parmar V S, Pati H N, Azim A. Kumar R, Himanshu, Bisht K S, Prasad A K & Errington W, Bioorg Med Chem, 109, 1998, 118.
16. Parmar V S, Prasad A K, Sharma, N K, Vardhan A, Pati H N, Sharma S K & Bisht K S, Chem Commun, 27, 1993.
17. Parmar V S. Prasad A K, Pati H N, Kumar R, Azim A, Roy S & Errington W, Bioorg Chem, 27, 1999, 119.
18. Parmar V S. Kumar A, Bisht K S, Mukherjee S, Prasad A K, Sharma S K, Wengel J & Olsen C E, Tetrahedron, 53, 1997, 2163.
19. Parmar V S, Kumar A, Prasad A K, Kumar R, Bisht K S, Poonam, Jain S C & Olsen C E, J Indian Chem Soc, 75, 1998, 810.
20. Singh R V & Tandon JP, Indian J Chem, 16A, 1978, 1062.
21. Whitesell J K & Reynolds D, J Org Chem, 48, 1983, 3548.
22. Kumar R, Azim A, Kumar V, Sharma S K, Prasad A K, Howarth OW, Olsen C E, Jain S C & Parmar V S, Bioorg Med Chem, 9, 2001, 2643.
23. Souter A, Mclean K J, Smith WE & Munro A W, J Chem Technol Biotechnol, 75, 2000, 933.
24. The WHO/IUATLD Global Project on Anti-tuberulosis Drug Resistance Surveillance 1997-2000 (available at http://www.who.int/dsa/cat98/tub8.htm#Anti-TB2).
25. A Guide for the Level III Laboratory, Public Health Mycobacteriology, Edited: T K Patrician & P K George (U S Department of Health and Human Services, Atlanta, Georgia), 1985, pp. 159-184.